Strongbridge Ireland Limited
Records under this name other than patents Strongbridge Ireland Limited holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 9 of 9 · Back to Strongbridge Ireland Limited
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,198,906 | Ketoconazole Enantiomer in Humans Formerly held In force · High confidence | In force | High confidence | |
| US 9,725,436 | Novel Cytochrome P450 Inhibitors and Their Method of Use Formerly held In force · High confidence | In force | High confidence | |
| US 10,039,801 | Pharmaceutical Compositions of Water Soluble Peptides with Poor Solubility in Isotonic Conditions and Methods for Their Use Formerly held In force · High confidence | In force | High confidence | |
| US 10,398,751 | Pharmaceutical Compositions of Water Soluble Peptides with Poor Solubility in Isotonic Conditions and Methods for Their Use Formerly held In force · High confidence | In force | High confidence | |
| US 10,987,402 | Pharmaceutical Compositions of Water Soluble Peptides with Poor Solubility in Isotonic Conditions and Methods for Their Use Formerly held In force · High confidence | In force | High confidence | |
| US 9,918,984 | Methods and Compositions for Treating Diabetes, Metabolic Syndrome and Other Conditions Formerly held Term ended Term ended Jan 10, 2026 · Medium confidence | Term ended | Term ended Jan 10, 2026 | Medium confidence |
| US 10,098,877 | Methods and Compositions for Treating Diabetes, Metabolic Syndrome and Other Conditions Formerly held Term ended Term ended Jan 10, 2026 · Medium confidence | Term ended | Term ended Jan 10, 2026 | Medium confidence |
| US 10,517,868 | Methods and Compositions for Treating Diabetes, Metabolic Syndrome and Other Conditions Formerly held Term ended Term ended Jan 10, 2026 · Medium confidence | Term ended | Term ended Jan 10, 2026 | Medium confidence |
| US 7,060,679 | Conformationally Constrained Backbone Cyclized Somatostatin Analogs Term ended Term ended Jun 19, 2018 · Medium confidence | Term ended | Term ended Jun 19, 2018 | Medium confidence |